CNV Analysis Boosts Genetic Testing for Pediatric Epilepsy
This study looked at the role of copy number variations (CNVs) in understanding the causes of epilepsy in children.
This hub covers pediatric epilepsy in infants, kids, and teens, including diagnosis, syndromes, development, school plans, and safety. New studies translated into clear takeaways for parents.
Usually when two appropriate medications haven’t controlled seizures.
Many families benefit and it depends on seizure frequency, medications, and learning needs.
Often yes, with smart precautions. Ask your neurologist or epileptologist about your child’s specific risks.
Clusters, prolonged seizures, breathing trouble, new weakness, or major regression.
This study looked at the role of copy number variations (CNVs) in understanding the causes of epilepsy in children.
A study was conducted to see if a mobile app called “Epilepto” could help children with drug-resistant epilepsy remember to take their medications.
Researchers studied how to improve the treatment of status epilepticus, a serious condition where a person has prolonged seizures, in children.
Researchers studied six Chinese children diagnosed with pyridoxine-dependent epilepsy (PDE) to understand the clinical features and genetic changes related to this condition.
Researchers studied a patient with severe muscle weakness, a condition known as arthrogryposis, and epilepsy that did not respond to treatment.
This study looked at how effective the ketogenic diet therapy (KDT) is for children with drug-resistant epilepsy caused by specific genetic mutations.
This study looked at the experiences of a child named Ethan who has Dravet syndrome, a severe form of epilepsy that starts in infancy.
This study focused on understanding the brain structure in a specific condition called focal cortical dysplasia (FCD), which is a common cause of epilepsy that does not respond well to medication.
This study looked at sudden unexpected death in epilepsy (SUDEP), which is a major cause of death related to epilepsy.